TTS Ltd., the University of California, San Francisco, and BayBio will be holding its 2013 edition of TTS North America this Monday and Tuesday, July 29-30, 2013, at the University of California, San Francisco, Mission Bay Campus in San Francisco, CA. The TTS Global Initiative is the leading international meeting for biotech sector Industry-academia licensing, partnering, and technology transfer. The TTS North America is the flagship summit of this key international initiative and community of leading technology transfer, licensing, IP, and early stage biotech innovation and venture professionals world wide.
A full program for TTS North America, including an agenda of each event's sessions and list of speakers can be obtained here. Patent Docs author Dr. Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will provide a presentation entitled "KOL Insight: The most important emerging trends & developments in biotech IP and their significance for TTOs and early stage biotech," and will also participate on a panel on "What crucial new developments in IP law and US legislation are of greatest concern to TTOs and early stage biotech and their investors?"
The registration fee for TTS North America is $599 (academic Innovators, university or Institute Technology Transfer Officers, non-governmental or non-profit organizations, and start-ups) or $999 (multinational, corporate, legal & consulting, and government). Patent Docs readers who register using the Code CJS13 and select the "Academic Rate" will be able to secure a registration fee of $399. Details regarding registration for the event can be found here.
Patent Docs and McDonnell Boehnen Hulbert & Berghoff LLP are partners of TTS North America.
Comments